Evidence shows that exercise is beneficial for people with multiple sclerosis (MS); however, statistical pooling of data is difficult because of the diversity of outcome measures used. The objective of this review is to report the recommendations of an International Consensus Meeting for a core set of outcome measures for use in exercise studies in MS. From the 100 categories of the International Classification of Function Core Sets for MS, 57 categories were considered as likely/ potentially likely to be affected by exercise and were clustered into seven core groups. Outcome measures to address each group were evaluated regarding, for example, psychometric properties. The following are recommended: Modified Fatigue Impact Scale (MFIS) or Fatigue Severity Scale (FSS) for energy and drive, 6-Minute Walk Test (6MWT) for exercise tolerance, Timed Up and Go (TUG) for muscle function and moving around, Multiple Sclerosis Impact Scale (MSIS-29) or Multiple Sclerosis Quality of Life-54 Instrument (MSQoL54) for quality of life and body mass index (BMI) or waist-hip ratio (WHR) for the health risks associated with excess body fat. A cost effectiveness analysis and qualitative evaluation should be included where possible. Using these core measures ensures that future meta-analyses of exercise studies in MS are more robust and thus more effectively inform practice.
Introduction
While the pharmaceutical industry has made advancements in identifying drug therapies to attenuate symptoms and disease progression for people with multiple sclerosis (MS), great strides have also been made with respect to non-pharmacologic interventions.
Exercise is a safe, non-pharmacological treatment strategy for people with MS that can bring many health benefits, including improvements in muscle power, physical and psychosocial functioning and quality of life. [1] [2] [3] Regular exercise participation may also have an important role to Core outcome measures for exercise studies in people with multiple sclerosis: recommendations from a multidisciplinary consensus meeting play in the management of fatigue, 4 which negatively affects quality of life, 5 mental alertness 6 and cognitive processing. 7 Although people with MS have traditionally been advised to refrain from exercise because of the increased risk of triggering an exacerbation of symptoms due to a rise in core temperature, 1 any increase in symptoms is usually transient (generally 30 minutes or less) and there is no evidence of lasting detrimental effects on fatigue or function. 8 Indeed, because of a rapidly expanding evidence base, exercise has become one of the key components of rehabilitation and long-term management of people with MS to optimise function and maintain health. In the United Kingdom (UK), the National Institute for Health and Care Excellence (NICE) recommends aerobic exercise for helping to control the burden of fatigue, motor weakness and musculoskeletal pain in people with MS. 9 This is supported by leading charitable trusts (e.g. the UK MS Society and MS Trust), which are actively promoting the benefits of exercise for improving mobility, mental health status and cardiovascular risk profile to enhance health-related quality of life (HRQoL) and reduce the MS health care burden.
Despite the growing evidence base, recent systematic and narrative reviews have highlighted the need for consensus on a core set of outcome measures for exercise studies. A key publication, the 2005 Cochrane Systematic Review, 1 reported that statistical pooling of the data from MS exercise studies was not possible because of the large number of outcome measures used and concluded that there was an urgent need for a consensus on a core set of outcome measures for exercise studies in MS to improve the robustness of future meta-analyses and to ensure that they more effectively inform clinical practice. Since then, a number of reviews on the effects of exercise for people with MS have been published yet the problem of multiple outcome measures and the resultant difficulty of statistical pooling remains.
For example, in their review, Asano et al. 10 stated that whilst there was evidence that exercise offered some benefits for people with MS, especially in terms of function and physical activity, advanced statistical analysis was not possible because of the amount and heterogeneity of outcome measures used. Dalgas et al. 11 reviewed the evidence for resistance, endurance and combined exercise and concluded that there were only a few methodologically poor and underpowered studies and thus, no conclusions could be made. The review also highlighted the large number of outcome measures included in the studies reviewed. Finally, Motl and Gosney 2 investigated the effects of exercise on quality of life (QOL) in people with MS and concluded that aerobic exercise in excess of 90 minutes per week can improve QOL but only if measured with a disease-specific QOL scale. Importantly, a total of 18 different QOL measures were used in 13 studies.
To advance clinical practice and develop guidelines for the application of exercise for people with MS, sufficient evidence of treatment effectiveness is essential. This involves expensive, large-scale studies or statistical pooling and meta-analysis of data from small-scale studies, which is currently hampered because of the heterogeneity of outcome measures used. Although the Cochrane Systematic Review in 2005 1 highlighted the need for a core set of outcomes, to date, this has not been proposed. Hence, a meeting of a group of international experts from a range of disciplines was held to discuss outcome measures in MS with the purpose being to recommend a core set of outcome measures for use within exercise studies in MS. This paper reports on the findings of this meeting.
Methods
The consensus group consisted of 12 people, most of whom were internationally recognised for their MS research. They came from a range of professional backgrounds: physiotherapy, exercise science, exercise psychology and health economics as well as a representative from the MS Society UK and two expert patients with MS. Participants attended from the UK, New Zealand, Ireland and the United States (USA). The MS Society UK sent a representative to the meeting and also assisted with recruiting the two individuals with MS through their research network. Funding was secured from the Multiple Sclerosis International Federation (MSIF) and the Consensus Meeting took place at the University of Glasgow on 15 and 16 of February 2012.
The Evaluation Database to Guide Clinical Effectiveness (EDGE) Task Force 12 of the American Physical Therapy Association had produced MS-EDGE outcome measures for acute, in-patient and out-patient management of people with MS and also for clinicians undertaking research. While this work primarily focused on clinical practice and specifically on physical therapy, the detailed evaluation by the EDGE group, e.g. outlining the validity and reliability of relevant outcome measures, was an invaluable resource. Therefore, following dialogue with the chair of the MS-EDGE group, these documents were used to support/ inform some of the discussion of the consensus meeting.
In the preparatory phase discussions took place, by email, in advance of the meeting. The group agreed that an overall framework was required to structure further discussion and for reporting recommendations for a core set of outcome measures. The group agreed that the International Classification of Functioning, Disability and Health (ICF) would be used as the framework (World Health Organisation (WHO) 2001), specifically the Core Sets for Multiple Sclerosis, which had recently been published. 13 The ICF Core Sets for MS contains 40 body functions, seven body structures and 53 activities and participation categories (100 categories) as well as 38 environmental categories in order to comprehensively describe the function and disability of people with MS based on the ICF. The ICF Core Sets for MS were used as the framework for determining the recommended core set of outcome measures for exercise studies in MS. However, as the environmental categories were part of the external factors, they were not included in the discussion as they could not be influenced by exercise.
At the meeting the group discussed the meaning and value of core outcomes and agreed that the core group of outcome measures should contain as few outcomes as possible but as many as necessary to cover the core domains affected by exercise. In addition the group identified that, for the core set of outcomes to have utility, they would have to be acceptable to various stakeholders: patients and their families, patient groups and charities, clinicians and researchers, research funding agencies, health funders/commissioners, ethics committees and journal editorial boards. The group listed and agreed factors and criteria which would be considered when discussing specific outcome measures (Table 1 ).
In Stage 1 of the structured review process, each of the 100 categories from the Core Sets for MS was discussed and classified as a) likely b) potentially likely or c) unlikely to be affected by exercise. As an example, under body functions, 'exercise tolerance' was classified as likely to be affected by exercise, 'urinary function' as potentially affected by exercise and 'fluency and rhythm of speech functions' as unlikely to be affected by exercise. Similarly, under activities and participation, 'transferring oneself' was classified as likely to be affected by exercise, 'higher education' as potentially affected by exercise and 'religion and spirituality' as unlikely to be affected by exercise. The results of Stage 1 are shown in Table 2 , which provides the list of categories likely, potentially like or unlikely to be affected by exercise. Forty categories were considered likely to be affected by exercise, 17 as potentially likely to be affected by exercise and 36 as unlikely to be affected by exercise (Table 2) . Those categories unlikely to be affected by exercise were then excluded from further discussion. The seven body structures were considered at the next stage.
In Stage 2, the categories deemed to be likely or potentially likely to be affected by exercise were then examined and, where relevant, combined into groups. For example 10 categories were clearly related to activities of daily living (ADL), e.g. dressing, eating and were therefore grouped into a category of ADL; 10 categories related to moving around, e.g. moving around in different locations, changing body position; and four categories were related to muscle function, e.g. muscle tone, muscle power.
Stage 2 resulted in eight groupings: energy and drive (fatigue), emotional function, exercise tolerance, muscle function, moving around, ADL, recreation and leisure and quality of life.
Also at this stage consideration was given to the seven body structures. These were mainly anatomical areas, e.g. structure of lower limb, brain, trunk, and as such likely to be affected by exercise but were discussed within the groupings identified. These were grouped under body structures, thus making nine groupings.
In Stage 3 each grouping was discussed in terms of whether assessment of that grouping in practice would be determined as a core part of the assessment in studies of exercise in MS. From this discussion, emotional function and recreation and leisure were not deemed to be core and therefore were not included in further discussion.
In Stage 4 the remaining seven groupings were considered in small groups. A list of possible outcome measures was drawn up which would address each grouping. The MS-EDGE documents were used as a resource for this stage. Each outcome measure was considered in relation to the specific criteria previously agreed (Table 1) .
In Stage 5 each small group provided a summary of their findings to the whole group. The group discussed and debated the utility of each measure and subsequently agreed on the outcome measure being recommended for each grouping.
In the final stage, Stage 6 the list of core outcome measures was considered by the group and final recommendations agreed. 
Factors considered
Psychometric properties of the outcome measure including reliability, validity, responsiveness to change Self-report or performance measure Generic or MS-specific measure The time taken to complete the assessment The patient/clinician/ administrator burden involved Any resources required including equipment, specialist skills, space The appropriateness of the measure across the disability range The specificity of the measure in terms of the type of exercise, e.g. aerobic, resistance Whether measures were under licence The availability of normative data Time frame, e.g. questionnaires relating to previous seven days or four weeks 
Results
The consensus group recommend that the outcome measures shown in Table 3 are used, where possible, in studies of exercise in MS. Table 4 shows further detail on the recommended outcomes in terms of the criteria in Table 1 .
The group recommended that, based on the current published literature available, all exercise-based research studies in people with MS should include measures of energy and drive (fatigue), exercise tolerance, muscle function, moving around, ADL, quality of life and body structures. For energy and drive (fatigue) the Modified Fatigue Impact Scale (MFIS) 16 is recommended as it encompasses a multidimensional assessment of fatigue however in situations where uni-dimensional assessment is sufficient the Fatigue Severity Scale (FSS) 17 could be used. For the assessment of exercise tolerance, the 6-Minute Walk Test (6MWT) 18 is recommended. The Timed Up and Go (TUG) 19 is recommended to assess both muscle function and moving around. For quality of life the Multiple Sclerosis Impact Scale (MSIS-29) 14 or Multiple Sclerosis Quality of Life-54 Instrument (MSQoL54) 15 are recommended and the simple measures of body mass index (BMI) or waist-hip ratio (WHR) are recommended as measures of body composition. 20 The group considered a measure of ADL to be important; however, it was not possible to recommend a suitable measure as none of the available measures met the necessary criteria ( Table 1) .
All the outcome measures recommended are appropriate across a range of disability with the exception of TUG and 6MWT, which are not appropriate for those who are nonambulatory. For those who are non-ambulatory, for the 'moving around' dimension, it was not possible to recommend a measure which was robust, valid and did not require a licence for use.
Although there was unanimous agreement of the importance of including assessments of cost-effectiveness, it was not possible to recommend one specific resource use measure because of the differing health care systems. Rather, the principle of taking a comprehensive approach to measuring service use and broader societal costs should be adopted and locally appropriate measures (e.g. patient questionnaires, administrative data) used for this. In some countries it is appropriate to combine cost data with quality-adjusted life years (QALYs) using a measure such as the EuroQuol 5D (EQ5D). 39 Where QALYs are not required for health care decision making, this approach may not be required.
The group also recommended that, where appropriate, the results of the quantitative measures recommended be supplemented with a qualitative evaluation. The latter is important to provide an understanding of the obtained results and to glean a more comprehensive perspective of how exercise programmes may affect people with MS.
Discussion
Our goal was to identify and select the most appropriate outcome measures for use in exercise-based research as one step in the process toward the application and evaluation of exercise in people with MS.
The outcome measures recommended by the consensus group are a combination of patient-reported outcome measures (PROMS); MSIS-29, MSQoL53, MFIS, FSS: rater/time-based tests; TUG, 6MWT, and objective measures: BMI, WHR. Schäffler et al. (2013) 40 suggest that such a combination is an appropriate triad of outcome measures, and in particular they highlight the growing importance of the inclusion of PROMS in the assessment of MS. Additionally the core outcomes consider a range of body structures, functions, activity limitations and participation restrictions in line with the ICF Core Sets for MS. 13 The core outcome measures recommended are commonly used assessments which are relatively quick to complete, require no specialised equipment or training and have minimal cost implications. It should therefore be feasible to include these outcome measures in most studies of exercise in MS. Also of note, with the exception of FSS and the body composition measures (BMI and WHR), all the core outcomes recommended are contained in the MS-EDGE Outcome Measures for Research (of which there are 27 recommended measures). The omission of the body composition measures (BMI and WHR) from the EDGE measures may be a reflection of this consensus group being multiprofessional, including exercise science, compared to the specific physical therapy focus of the EDGE group. The inclusion of body composition measures BMI and WHR, Each laboratory to determine its own reliability data.
Hip circumference is measured at the widest portion of the buttocks and waist circumference is measured at the narrowest part of the torso between the iliac crest. In obese people, waist circumference is measured on a horizontal plane around the abdomen at the level of the iliac crest. 20 Self-report or performance measure Self-report Self-report Self-report which assess the health risks associated with excess body fat, is viewed as a strength of the recommended core group of outcome measures, as their inclusion allows the research/ practise agenda to move beyond the symptom management/disability focus and to consider the role of exercise in the prevention of secondary health problems such as cardiovascular disease and diabetes in people with MS. Importantly, the outcome measures recommended are not intended as the only measures for use in exercise studies but that these core measures are included within the battery of relevant outcome measures of individual studies. For example, a study designed to investigate the effects of resistance muscle training would include outcome measures such as muscle strength or power but would also include the recommended core outcome measures.
In our discussion of the two related areas of ADL and 'moving around' for those who are non-ambulatory, we determined that no measure was available which fulfilled our criteria for inclusion as an outcome measure (Table  1) . Although there are many ADL measures, most require specific training in their use, e.g. the Functional Independence Measure (FIM) or require a licence, e.g. the Canadian Occupational Performance Measure (COPM). These measures are well validated within the literature; however, because of accessibility issues they are not appropriate within a core set of outcome measures. The difficulty in recommending a specific measure in this area may be a reflection of the literature base being focussed mainly on the effects of exercise in those with relapsing-remitting forms of the disease with relatively few studies investigating the effects of exercise for those with progressive MS. There is an urgent need to develop a robust, easily accessible outcome measure to evaluate ADL and 'moving around' in people with MS who are non-ambulatory.
We propose that these outcome measures be reviewed regularly, at least every five years. This is important in light of the evolving evidence base, the publication of new outcome measures and the continued validation/update of existing outcome measures. For example the Neurological Fatigue Index for Multiple Sclerosis (NFI-MS) 41 and the Fatigue Scale for Motor and Cognitive Functions (FSMC) 42 are relatively new measures of fatigue. These were considered but at the time of the consensus meeting there was insufficient evidence on their psychometric properties or their research utility to consider them for inclusion as a core outcome measure. However, when the core outcomes are reviewed the results of recent studies 41, 43, 44 may provide stronger evidence to support their inclusion.
Limitations
The consensus group was relatively small, all English speaking and, although it was multidisciplinary, it did not include representatives from some relevant professional groups such as occupational therapists which would have been valuable. While the group contained internationally leading researchers and expert reviewers for the MS Society, budgetary restrictions limited the number of geographical locations represented. It is possible that a different group of researchers might recommend a different set of core measures; however, it should be noted that consensus was achieved by those present.
All the core outcome measures are widely used and available in English formats. Future reviews of the core outcome measures should consider if these outcomes are validated in a range of different languages to support the use of the core outcomes in countries where English is not the principal language.
Conclusion
The consensus group recommendations are that all exercise studies in MS include the following outcome measures: the MSIF or the FSS, the 6MWT, the TUG, the MSIS-29 or MSQoL54 and BMI or WHR. These measures should not be to the exclusion of others relevant to the research question(s) of specific studies. Where possible, it is recommended that the core outcome measures be augmented by qualitative evaluation and an assessment of the cost/benefit of the exercise intervention, based on local nationally accepted methods, be included.
